Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 2
2006 3
2007 4
2008 3
2009 3
2010 4
2011 12
2012 11
2013 12
2014 13
2015 11
2016 8
2017 5
2018 5
2019 6
2020 8
2021 6
2022 6
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
Hepatic Stellate Cells in Liver Tumor.
Shiraha H, Iwamuro M, Okada H. Shiraha H, et al. Adv Exp Med Biol. 2020;1234:43-56. doi: 10.1007/978-3-030-37184-5_4. Adv Exp Med Biol. 2020. PMID: 32040854 Review.
Human hepatocyte carcinogenesis (review).
Shiraha H, Yamamoto K, Namba M. Shiraha H, et al. Int J Oncol. 2013 Apr;42(4):1133-8. doi: 10.3892/ijo.2013.1829. Epub 2013 Feb 19. Int J Oncol. 2013. PMID: 23426905 Free PMC article. Review.
The prediction of early progressive disease in patients with hepatocellular carcinoma receiving atezolizumab plus bevacizumab.
Takeuchi Y, Nouso K, Fujioka SI, Kariyama K, Kobashi H, Uematsu S, Moriya A, Hagihara H, Takabatake H, Nakamura S, Yabushita K, Kikuchi T, Oyama A, Adachi T, Wada N, Onishi H, Shiraha H, Takaki A. Takeuchi Y, et al. Among authors: shiraha h. Cancer Med. 2023 Sep;12(17):17559-17568. doi: 10.1002/cam4.6369. Epub 2023 Aug 3. Cancer Med. 2023. PMID: 37537956 Free PMC article.
All carbonated beverages effectively dissolve phytobezoars.
Iwamuro M, Yamauchi K, Shiraha H, Okada H. Iwamuro M, et al. Among authors: shiraha h. Clin Res Hepatol Gastroenterol. 2018 Sep;42(4):e66-e67. doi: 10.1016/j.clinre.2018.01.003. Epub 2018 Jun 11. Clin Res Hepatol Gastroenterol. 2018. PMID: 29903611 No abstract available.
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab.
Kikuchi T, Takeuchi Y, Nouso K, Kariyama K, Kuwaki K, Toshimori J, Iwado S, Moriya A, Hagihara H, Takabatake H, Tada T, Yasunaka T, Sakata M, Sue M, Miyake N, Adachi T, Wada N, Onishi H, Shiraha H, Takaki A, Otsuka M. Kikuchi T, et al. Among authors: shiraha h. Liver Int. 2024 Jun;44(6):1456-1463. doi: 10.1111/liv.15907. Epub 2024 Mar 15. Liver Int. 2024. PMID: 38488749
118 results